Red Flags Detected
- Delisting (new) — Company received second Nasdaq notice for failure to maintain $1.00 minimum bid price and has been granted a final extension until November 16, 2026 to regain compliance or face potential delisting.
Envoy Medical gets second Nasdaq extension until Nov 2026, plans reverse split if needed
Filed May 22, 2026 · Period ending May 19, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade COCHW commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 25, 2026 11:40 AM